Performance analysis of Oramed Pharmaceuticals (ORMP)
Annual Return
Over the past 3 years, ORMP has had an average annual return of +10.66%, underperforming the benchmark SPY, which returned +19.63% annual.
Over the past 5 years, ORMP has had an average annual return of -19.96%, underperforming the benchmark SPY, which returned +12.73% annual.
Over the past 10 years, ORMP has had an average annual return of -6.11%, underperforming the benchmark SPY, which returned +15.04% annual.
Since Apr 21, 2006, ORMP has had an average annual return of -4.95%, underperforming the benchmark SPY, which returned +11% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +50.65% | +17.75% | +4.78% | -80.80% | -15.76% | +236.82% | -17.68% | +71.68% | -66.67% | +47.06% | -28.42% | +87.50% |
| 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
| -70.45% | +289.64% | +17.86% | -6.67% | -33.33% | +15.38% | +50% | -69.05% | -16.00% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +26.27% | +1.33% | -0.43% | +14.11% | +2.32% | +21.17% | -16.42% | +50.65% | |||||
| 2025 | -7.44% | -6.70% | +2.35% | +8.41% | +0.88% | -3.85% | -4.43% | +2.29% | +20.02% | -9.45% | +19.23% | +0% | +17.75% |
| 2024 | +29.66% | +9.86% | -11.27% | -20.55% | -6.00% | +17.89% | -0.79% | -6.26% | +2.06% | -2.46% | -0.40% | +2.13% | +4.78% |
| 2023 | -83.46% | +5.55% | +3.83% | +4.13% | +77.96% | -11.40% | -5.30% | -3.26% | -20.42% | -29.89% | +21.31% | +4.05% | -80.80% |
| 2022 | -37.25% | +14.95% | -16.02% | -40.58% | -9.92% | -1.06% | +91.70% | -2.51% | -24.30% | +9.72% | +18.85% | +42.36% | -15.76% |
| 2021 | +71.24% | +22.73% | +14.03% | +4.91% | +8.07% | +16.15% | +6.05% | +38.69% | +11.69% | +6.50% | -17.90% | -25.70% | +236.82% |
| 2020 | +1.54% | -21.98% | -25.50% | +1.66% | +1.63% | +12.42% | +3.94% | -4.91% | -25.21% | -3.08% | +68.41% | -0.48% | -17.68% |
| 2019 | +5% | +1.60% | +13.72% | +0.82% | -18.25% | +19.68% | +1.94% | -9.28% | -3.94% | -0.30% | +38.68% | +16.79% | +71.68% |
| 2018 | -9.56% | -10.92% | -10.21% | +3.69% | +17.19% | -6.07% | -28.13% | -7.30% | -1.62% | -13.33% | -3.33% | -26.47% | -66.67% |
| 2017 | +7.02% | -7.62% | +1.65% | +26.01% | +5.17% | -4.67% | +3.86% | +7.18% | +14.80% | -0.10% | -7.86% | -1.54% | +47.06% |
Drawdown analysis of Oramed Pharmaceuticals (ORMP)
The maximum drawdown for the ORMP was -94.25%, occurring on Nov 1, 2023. This drawdown has not yet recovered.
The current ORMP drawdown is -85.57%.
Since Apr 21, 2006 ORMP has experienced the following drawdowns:
- 50% or more: 3 times
- 40% or more: 3 times
- 30% or more: 3 times
- 20% or more: 4 times
- 10% or more: 6 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -94.25% | Nov 8, 2021 | 498 | Nov 1, 2023 | Ongoing | Ongoing | Ongoing |
| -91.59% | Jan 10, 2014 | 1476 | Nov 20, 2019 | 495 | Nov 8, 2021 | 1971 |
| -82.50% | Jun 21, 2006 | 381 | Dec 26, 2007 | 1510 | Dec 24, 2013 | 1891 |
| -21.26% | Dec 24, 2013 | 1 | Dec 26, 2013 | 2 | Dec 30, 2013 | 3 |
| -19.00% | Apr 21, 2006 | 22 | May 23, 2006 | 1 | May 24, 2006 | 23 |
| -13.64% | May 31, 2006 | 9 | Jun 13, 2006 | 6 | Jun 21, 2006 | 15 |
| -1.05% | Jan 2, 2014 | 1 | Jan 3, 2014 | 2 | Jan 7, 2014 | 3 |
| -1.01% | Jan 8, 2014 | 1 | Jan 9, 2014 | 1 | Jan 10, 2014 | 2 |
| -0.98% | May 24, 2006 | 2 | May 26, 2006 | 2 | May 31, 2006 | 4 |